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Oxalic acid (OA), a metabolite ofethylene
glycol, was selected for testing in the RACB
protocol based on the biological activity of
the parent compound (Morrissey et al.,
FundamAppl Toxicol 13:747-777 [1989]).
It was part ofa series ofglycol ethers, con-
geners, and metabolites evaluated for struc-
ture-activity correlations using this design.
Data collected on body weights, clinical
signs, and food and water consumption
during the dose-range-finding segment
(Task 1) were used to set concentrations for
the main study (Task 2) at 0.05, 0.10, and
0.2% OA in drinking water. These concen-
trations reduced water consumption in the
middle and high dose groups byless than or
equal to 25%, and yielded calculated con-
sumption estimates ofapproximately 89,
162, and 275 mg OA/kg/day. There were
no adverse dinical signs.
One female died in both the low and
middle dose groups. At 0.2% OA, the
number oflitters per pair was reduced by
5% and the pup weight adjusted for litter
size was reduced byapproximately 4%; sire
and dam weights were not affected during
Task 2. For the last litter born in Task 2,
body weights and pup number were
recorded for the controls and 0.1 and 0.2%
OA groups; there were no treatment-
related changes in pup survival or weight
gain to postnatal day 14.
Based on the fact that a modest degree
ofeffect seen at the top dose group in Task
2 was identified only after summing all the
Task 2 litter data, it was predicted that the
single litter produced in Task 3 would be
insufficient to help determine the affected
sex. Thus, the last litter from the control
and high dose animals were reared for
testing inTask4.
After the Task 4 mice were weaned, ten
Fo mice from the control and 0.2% groups
were killedand necropsied. No changeswere
seen in body or organ weights from females.
For males, the only significant effect was a
19% decrease in prostate weight at 0.2%
OA. Total calcium levels in bloodwere mea-
sured for 10 mice ofeach sex in the control
and 0.2% OA groups; the control level of
9.4 mg/dlwas unchanged dueto treatment.
In the Task 4 1-week mating trial, there
was a 20% reduction in the number oflive
pups per litter delivered by the 0.2% OA
group. No other differences were observed.
After 7 days ofvaginal lavage, the Fl mice
were killed and necropsied. While terminal
body weight was unchanged in either sex,
female kidney weight (adjusted for body
weight) was increased by 10% in the OA-
treated females. There were no other
changes in organ weights. The percent of
abnormal sperm forms increased from 2.2%
in controls to 4.0% in the 0.2% OA group.
Serum calcium levels in either sex were
unchangedfrom control levels of7.9 mg/dl.
In summary, in the F0 mice, oxalic acid
at these levels reduced water consumption,
and reduced the number oflitters per pair,
adjusted pup weight, and prostate weight in
the absence of detected somatic organ
changes. In Fl mice, an increase in kidney
weight occurred concomitant with a reduc-
tion in the number oflive pups per litter,
and increased abnormal sperm forms. Ifthe
kidney weight effect is the result ofreduced
water consumption, then it can be con-
cluded that oxalic acid is a reproductive tox-
icant in Swiss CD-1 mice at concentrations
that reduce parental water consumption,
butthat cause fewothersomaticeffects.
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Summary: NTP Reproductive Assessment byContinuous Breeding Study.
NTIS#: 86167053/AS
Chemical: Oxalic Acid
CAS#: 144-62-7
Mode ofexposure: Drinking water
Species/strain: Swiss CD-1 mice
F0generation Dose concentration -4 0.05% 0.10% 0.20%
Bodyweight _, _
Kidneyweight8
Liverweight8 ..... .-
Mortality .
Feedconsumption * *
Waterconsumption - 4 4,4,
Clinical signs _ _ , _
2litters/pair J_
# livepups/litter; pupwt./litter - - -,
Cumulative days tolifter_ _ __ _ -
Absolutetestis,epididymisweight8 * * * * , -
Sexaccessoryglandweight8(prostate, seminalvesicle) * * * * ,,-
Epidid. sperm parameters (#, motility, morphology) * * *
Estrouscycle length
Determination ofaffected sex(crossover) ] Male ] Female [ Both
Dose level J * J *
F, generation Dose concentration -4 0.05% 0.10% 0.20%
Pupgrowth toweaning * *_ _*
Mortality * * * * - -
Adult bodyweight * * * *- -
Kidneyweighta _ ''''''''' _=_-''---'-'-
Liverweight8 *-
Feedconsumption * * *
Waterconsumption * * * * -,-
Clinicalsigns * * * * - -
Fertility index . ._T -_
#livepups/litter; pupwt./litter *,* I *_-_T_ _- I
Absolutetestis, epididymisweighta ___ _ - -
Sexaccessoryglandweighta(prostate, seminalvesicle) I j *. IT _-_I
Epidid. sperm parameters (#,motility, morphology) ._ ._.___.T. T . . I
Estrous cycle length _ -
Affected sex? Unclear
Studyconfounders: None
NOAELreproductivetoxicity: Notdetermined NOAELgeneraltoxicity: Notdetermined
F, more sensitivethanFo? Unclear
Postnataltoxicity: No
Legend:-, no change; *, no observation; TI or4,, statistically significant change(p<0.05); - , nochange in males orfemales. "Adjusted forbodyweight.
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